Skip to Main Content

Author Details

Viviana Simon
Icahn School of Medicine at Mount Sinai
1997
158
49
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36271493Evaluation and validation of an RT-PCR assay for specific detection of monkeypox virus (MPXV).J Med Virol2023
37808679Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.bioRxiv2023
37797027Mapping SARS-CoV-2 antigenic relationships and serological responses.Science2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
38092666Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.mBio2023
35860221Mapping SARS-CoV-2 antigenic relationships and serological responses.bioRxiv2023
37322614Genomic and ultrastructural analysis of monkeypox virus in skin lesions and in human/animal infected cells reveals further morphofunctional insights into viral pathogenicity.J Med Virol2023
37212288Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.J Med Virol2023
37141905Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies.Lancet Microbe2023
37104046Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections.J Infect Dis2023
37270625Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants.Nat Commun2023
37475115Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.Lancet Infect Dis2023
37162953Development of a Novel Serological Assay for the Detection of Mpox Infection in Vaccinated Populations.medRxiv2023
36539526Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines.Nat Rev Immunol2023
36533948Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.J Virol2023
36862518Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.J Clin Invest2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
36791207An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.Sci Transl Med2023
36927408Phylogenetic landscape of Monkeypox Virus (MPV) during the early outbreak in New York City, 2022.Emerg Microbes Infect2023
34669506Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.J Virol2022
35617826Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.EBioMedicine2022
35586986PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.mSphere2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35703544The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.mSphere2022
35467422Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain.mBio2022
35857646Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.N Engl J Med2022
35499323Heterogeneity of Latency Establishment in the Different Human CD4<sup>+</sup> T Cell Subsets Stimulated with IL-15.J Virol2022
35665019A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants.medRxiv2022
35525388RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City.J Mol Diagn2022
35784650Development of an HIV reporter virus that identifies latently infected CD4<sup>+</sup> T cells.Cell Rep Methods2022
35446141Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.J Virol2022
36406863Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients.iScience2022
36543789Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.Nat Commun2022
36044897Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.Med2022
36069609A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants.Microbiol Spectr2022
35997286SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.mBio2022
36069438Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model.mSphere2022
36115801mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations.Vaccine2022
35186917Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations.Front Cell Dev Biol2022
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
35243662Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.J Med Virol2022
34877674Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multitarget approach.J Med Virol2022
35333911ISG15 deficiency restricts HIV-1 infection.PLoS Pathog2022
35262095The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.medRxiv2022
32761908The arrival and spread of SARS-CoV-2 in Colombia.J Med Virol2021
33568453Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.mSphere2021
33593910Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.Proc Natl Acad Sci U S A2021
33758878The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.medRxiv2021
  • 1 - 50 of 158

Recommended Authors

University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 13
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 4
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 14
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 3
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year 2004
Number of shared co-authors 4
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
University of California san francisco
Career Start Year 2002
Number of shared co-authors 3
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 8
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 8
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 2
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 10
University College London
Career Start Year 1995
Number of shared co-authors 24
University of Washington
Career Start Year 1995
Number of shared co-authors 2
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 6
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 8
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
University of California san francisco
Career Start Year 1988
Number of shared co-authors 13
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 1
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 7
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 20
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 24
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 6
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 11
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 6
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 7
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 8

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 33
Icahn School of Medicine at Mount Sinai
Co-authored papers 28
Icahn School of Medicine at Mount Sinai
Co-authored papers 27
Icahn School of Medicine at Mount Sinai
Co-authored papers 21
Icahn School of Medicine at Mount Sinai
Co-authored papers 19
Icahn School of Medicine at Mount Sinai
Co-authored papers 17
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Co-authored papers 12
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Co-authored papers 11
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Co-authored papers 9
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Drukier Institute for Children's Health
Co-authored papers 6
Influenza Research Institute, University of Wisconsin
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 5
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Duke University School of Medicine
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Co-authored papers 4
Rockefeller University
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Co-authored papers 4
Paul-Ehrlich-Institut
Co-authored papers 4
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3